These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 17976883)

  • 1. Environment, diet and CpG island methylation: epigenetic signals in gastrointestinal neoplasia.
    Johnson IT; Belshaw NJ
    Food Chem Toxicol; 2008 Apr; 46(4):1346-59. PubMed ID: 17976883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic silencing mediated by CpG island methylation: potential as a therapeutic target and as a biomarker.
    Teodoridis JM; Strathdee G; Brown R
    Drug Resist Updat; 2004; 7(4-5):267-78. PubMed ID: 15533764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New approaches to the role of diet in the prevention of cancers of the alimentary tract.
    Johnson IT
    Mutat Res; 2004 Jul; 551(1-2):9-28. PubMed ID: 15225578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CpG island mapping by epigenome prediction.
    Bock C; Walter J; Paulsen M; Lengauer T
    PLoS Comput Biol; 2007 Jun; 3(6):e110. PubMed ID: 17559301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic mechanisms and gastrointestinal development.
    Waterland RA
    J Pediatr; 2006 Nov; 149(5 Suppl):S137-42. PubMed ID: 17212956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Change of epigenetic control of cystathionine beta-synthase gene expression through dietary vitamin B12 is not recovered by methionine supplementation.
    Uekawa A; Katsushima K; Ogata A; Kawata T; Maeda N; Kobayashi K; Maekawa A; Tadokoro T; Yamamoto Y
    J Nutrigenet Nutrigenomics; 2009; 2(1):29-36. PubMed ID: 19776636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning.
    Hinshelwood RA; Melki JR; Huschtscha LI; Paul C; Song JZ; Stirzaker C; Reddel RR; Clark SJ
    Hum Mol Genet; 2009 Aug; 18(16):3098-109. PubMed ID: 19477956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unraveling the epigenetic code of cancer for therapy.
    Smith LT; Otterson GA; Plass C
    Trends Genet; 2007 Sep; 23(9):449-56. PubMed ID: 17681396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic events associated with breast cancer and their prevention by dietary components targeting the epigenome.
    Khan SI; Aumsuwan P; Khan IA; Walker LA; Dasmahapatra AK
    Chem Res Toxicol; 2012 Jan; 25(1):61-73. PubMed ID: 21992498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The social environment and the epigenome.
    Szyf M; McGowan P; Meaney MJ
    Environ Mol Mutagen; 2008 Jan; 49(1):46-60. PubMed ID: 18095330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetics and cancer: towards an evaluation of the impact of environmental and dietary factors.
    Herceg Z
    Mutagenesis; 2007 Mar; 22(2):91-103. PubMed ID: 17284773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of DNA damage and alterations in cytosine DNA methylation in rat liver carcinogenesis induced by a methyl-deficient diet.
    Pogribny IP; Shpyleva SI; Muskhelishvili L; Bagnyukova TV; James SJ; Beland FA
    Mutat Res; 2009 Oct; 669(1-2):56-62. PubMed ID: 19442675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamics, stability and inheritance of somatic DNA methylation imprints.
    Sontag LB; Lorincz MC; Georg Luebeck E
    J Theor Biol; 2006 Oct; 242(4):890-9. PubMed ID: 16806276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic changes in cancer.
    Grønbaek K; Hother C; Jones PA
    APMIS; 2007 Oct; 115(10):1039-59. PubMed ID: 18042143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CpG-island methylation and epigenetic control of resistance to chemotherapy.
    Teodoridis JM; Strathdee G; Plumb JA; Brown R
    Biochem Soc Trans; 2004 Dec; 32(Pt 6):916-7. PubMed ID: 15506923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variable DNA methylation patterns associated with progression of disease in hepatocellular carcinomas.
    Gao W; Kondo Y; Shen L; Shimizu Y; Sano T; Yamao K; Natsume A; Goto Y; Ito M; Murakami H; Osada H; Zhang J; Issa JP; Sekido Y
    Carcinogenesis; 2008 Oct; 29(10):1901-10. PubMed ID: 18632756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation-related aberrant patterns of DNA methylation: detection and role in epigenetic deregulation of cancer cell transcriptome.
    Suzuki H; Toyota M; Kondo Y; Shinomura Y
    Methods Mol Biol; 2009; 512():55-69. PubMed ID: 19347273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CpG island methylator phenotype (CIMP) in cancer: causes and implications.
    Teodoridis JM; Hardie C; Brown R
    Cancer Lett; 2008 Sep; 268(2):177-86. PubMed ID: 18471961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoter analysis of epigenetically controlled genes in bladder cancer.
    Veerla S; Panagopoulos I; Jin Y; Lindgren D; Höglund M
    Genes Chromosomes Cancer; 2008 May; 47(5):368-78. PubMed ID: 18196590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New perspectives on folate transport in relation to alcoholism-induced folate malabsorption--association with epigenome stability and cancer development.
    Hamid A; Wani NA; Kaur J
    FEBS J; 2009 Apr; 276(8):2175-91. PubMed ID: 19292860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.